FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2156388049> ?p ?o ?g. }

• W2156388049 endingPage "862" @default.
• W2156388049 startingPage "854" @default.
• W2156388049 abstract "Background In a study of childhood acute lymphoblastic leukemia (CoALL 06-97 study), the in vitro sensitivity of the patients’ cells to prednisolone, vincristine and asparaginase was introduced as a new additional risk parameter for treatment stratification. In parallel in vivo treatment response was assessed by determining the presence and extent of minimal residual disease in a subset of patients (n=224). Here we report the long-term impact of in vitro sensitivity-based risk stratification according to survival and compare the results of in vitro sensitivity with in vivo response.Design and Methods Patients with a sensitive in vitro profile were treated with a reduced intensity protocol (n=167) whereas patients defined as low risk according to conventional parameters but with a resistant in vitro profile were given intensified therapy (n=47).Results At a median follow-up of 6.8 years event-free survival was 0.80±0.03 for patients with a sensitive profile, 0.73±0.03 for those with an intermediate profile and 0.67±0.08 for those with a resistant profile (P=0.015). Overall, the treatment results of the cases stratified according to in vitro sensitivity were similar to those of the historical control group stratified based on conventional risk factors. Minimal residual disease at the end of induction was a strong predictor of outcome in B-precursor and T-cell acute lymphoblastic leukemia. There was no correlation between in vitro and in vivo treatment response in B-precursor leukemia (Spearman’s r=0.13; P=0.15) in contrast to T-cell acute lymphoblastic leukemia (Spearman’s r=0.63; P" @default.
• W2156388049 created "2016-06-24" @default.
• W2156388049 creator A5006014064 @default.
• W2156388049 creator A5013926334 @default.
• W2156388049 creator A5022986622 @default.
• W2156388049 creator A5024275910 @default.
• W2156388049 creator A5035292815 @default.
• W2156388049 creator A5035786690 @default.
• W2156388049 creator A5039944374 @default.
• W2156388049 creator A5043037950 @default.
• W2156388049 creator A5049006589 @default.
• W2156388049 creator A5061408567 @default.
• W2156388049 creator A5070688892 @default.
• W2156388049 creator A5075479908 @default.
• W2156388049 creator A5085985852 @default.
• W2156388049 creator A5090678844 @default.
• W2156388049 date "2011-02-17" @default.
• W2156388049 modified "2023-10-10" @default.
• W2156388049 title "The long-term impact of in vitro drug sensitivity on risk stratification and treatment outcome in acute lymphoblastic leukemia of childhood (CoALL 06-97)" @default.
• W2156388049 cites W104411260 @default.
• W2156388049 cites W1490168836 @default.
• W2156388049 cites W1576233656 @default.
• W2156388049 cites W1588244760 @default.
• W2156388049 cites W1972467214 @default.
• W2156388049 cites W1972954377 @default.
• W2156388049 cites W1976897536 @default.
• W2156388049 cites W1978709366 @default.
• W2156388049 cites W1979300931 @default.
• W2156388049 cites W1986846017 @default.
• W2156388049 cites W2001093266 @default.
• W2156388049 cites W2014804837 @default.
• W2156388049 cites W2015485265 @default.
• W2156388049 cites W2020980159 @default.
• W2156388049 cites W2025743629 @default.
• W2156388049 cites W2034592954 @default.
• W2156388049 cites W2053754416 @default.
• W2156388049 cites W2053852136 @default.
• W2156388049 cites W2071818770 @default.
• W2156388049 cites W2071899049 @default.
• W2156388049 cites W2085933860 @default.
• W2156388049 cites W2100956382 @default.
• W2156388049 cites W2103347449 @default.
• W2156388049 cites W2129291628 @default.
• W2156388049 cites W2141570612 @default.
• W2156388049 cites W2145503918 @default.
• W2156388049 cites W2148631711 @default.
• W2156388049 cites W2151069914 @default.
• W2156388049 cites W2156840245 @default.
• W2156388049 cites W2159867532 @default.
• W2156388049 cites W2314097375 @default.
• W2156388049 cites W2325430101 @default.
• W2156388049 cites W2328999771 @default.
• W2156388049 cites W2333196452 @default.
• W2156388049 cites W2404703750 @default.
• W2156388049 doi "https://doi.org/10.3324/haematol.2010.039735" @default.
• W2156388049 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/3105647" @default.
• W2156388049 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/21330320" @default.
• W2156388049 hasPublicationYear "2011" @default.
• W2156388049 type Work @default.
• W2156388049 sameAs 2156388049 @default.
• W2156388049 citedByCount "21" @default.
• W2156388049 countsByYear W21563880492012 @default.
• W2156388049 countsByYear W21563880492013 @default.
• W2156388049 countsByYear W21563880492015 @default.
• W2156388049 countsByYear W21563880492016 @default.
• W2156388049 countsByYear W21563880492017 @default.
• W2156388049 countsByYear W21563880492018 @default.
• W2156388049 countsByYear W21563880492019 @default.
• W2156388049 countsByYear W21563880492020 @default.
• W2156388049 countsByYear W21563880492021 @default.
• W2156388049 countsByYear W21563880492023 @default.
• W2156388049 crossrefType "journal-article" @default.
• W2156388049 hasAuthorship W2156388049A5006014064 @default.
• W2156388049 hasAuthorship W2156388049A5013926334 @default.
• W2156388049 hasAuthorship W2156388049A5022986622 @default.
• W2156388049 hasAuthorship W2156388049A5024275910 @default.
• W2156388049 hasAuthorship W2156388049A5035292815 @default.
• W2156388049 hasAuthorship W2156388049A5035786690 @default.
• W2156388049 hasAuthorship W2156388049A5039944374 @default.
• W2156388049 hasAuthorship W2156388049A5043037950 @default.
• W2156388049 hasAuthorship W2156388049A5049006589 @default.
• W2156388049 hasAuthorship W2156388049A5061408567 @default.
• W2156388049 hasAuthorship W2156388049A5070688892 @default.
• W2156388049 hasAuthorship W2156388049A5075479908 @default.
• W2156388049 hasAuthorship W2156388049A5085985852 @default.
• W2156388049 hasAuthorship W2156388049A5090678844 @default.
• W2156388049 hasBestOaLocation W21563880491 @default.
• W2156388049 hasConcept C126322002 @default.
• W2156388049 hasConcept C143998085 @default.
• W2156388049 hasConcept C150903083 @default.
• W2156388049 hasConcept C202751555 @default.
• W2156388049 hasConcept C203014093 @default.
• W2156388049 hasConcept C207001950 @default.
• W2156388049 hasConcept C2776694085 @default.
• W2156388049 hasConcept C2776755627 @default.
• W2156388049 hasConcept C2778461978 @default.
• W2156388049 hasConcept C2778904437 @default.
• W2156388049 hasConcept C2779429289 @default.

• next